Informing optimal duration of adjuvant chemotherapy (ACT) in resected stage I-IV colorectal cancer (CRC) based on early circulating tumor DNA (ctDNA) dynamics.
Year: 2026
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Hiroyuki Yamamoto, Hideaki Bando, Yoshiaki Nakamura, Daisuke Kotani, Saori Mishima, Koji Ando, Daryanaz Dargahi, Tony Tin, Charuta C. Palsuledesai, Meenakshi Malhotra, Dina Hafez, Steven Sorscher, Robert William Lentz, Minetta C. Liu, Adham A. Jurdi, Hiroya Taniguchi, Jun Watanabe, Takeshi Kato, Takayuki Yoshino, Eiji Oki
Institutions: Teine Keijinkai Hospital, National Cancer Center Hospital East, Kyushu University, Natera (United States), University of Colorado Anschutz, Aichi Cancer Center, Yokohama City University Medical Center, Yokohama City University Hospital, Osaka National Hospital, Kyushu University Hospital
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7162488404